Integra LifeSciences Schedules Conference Call for Wednesday, April 28 to Discuss First Quarter 2004 Financial Results and Update Forward-Looking Financial Guidance
PLAINSBORO, N.J.--(BUSINESS WIRE)--April 14, 2004--Integra LifeSciences Holdings Corporation (Nasdaq:IART) has scheduled a conference call for 9:00 AM ET on Wednesday, April 28 to discuss financial results for the first quarter ended March 31, 2004 and to update forward-looking financial guidance. Financial results for the first quarter 2004 will be announced via a news release issued after the market closes on April 27.
The conference call will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, and will be open to all listeners. Additional forward-looking information may be discussed in a question and answer session following the call.
Access to the live call is available by dialing 973-935-8512 or through a webcast via a link provided on Integra's website at www.Integra-LS.com. Access to a replay is available through May 12, 2004 by dialing 973-341-3080 (PIN 4664385) or through the webcast.
Integra LifeSciences Holdings Corporation is a diversified medical technology company that develops, manufactures, and markets medical devices for use in a variety of applications. The primary applications for Integra's products are neuro-trauma and neurosurgery, plastic and reconstructive surgery and general surgery. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Our corporate headquarters are in Plainsboro, New Jersey, and we have manufacturing and research facilities located throughout the world.
CONTACT: Integra LifeSciences Holdings Corporation
Maria Platsis, 609-936-2333
mplatsis@integra-ls.com
John Bostjancic, 609-936-2239
jbostjancic@integra-ls.com
SOURCE: Integra LifeSciences Holdings Corporation